Want to join the conversation?
In 1Q16, $AA posted revenues in its Arconic or Value-Add segment of $3.3Bil, down 2.2% YoverY. After-tax operating income was $269M, up 8% YoverY. In the Upstream segment, total revenue was $2.1Bil and after-tax operating income was $22MM.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.